SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-08-037489
Filing Date
2008-06-06
Accepted
2008-06-06 17:52:40
Documents
1
Period of Report
2008-06-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd207489.html 4  
1 FORM 4 rrd207489.xml 4 3648
  Complete submission text file 0001181431-08-037489.txt   5780
Mailing Address 3625 132ND AVENUE SE SUITE 400 BELLEVUE WA 98006
Business Address 3625 132ND AVENUE SE SUITE 400 BELLEVUE WA 98006 4253730171
SCOLR Pharma, Inc. (Issuer) CIK: 0000934936 (see all company filings)

IRS No.: 911689591 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1

Mailing Address C/O SCOLR PHARMA INC 3625 - 132ND AVENUE SE, SUITE 300 BELLEVUE WA 98006
Business Address (425) 373-0171
FASSIHI REZA (Reporting) CIK: 0001270083 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31982 | Film No.: 08886679